Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)
Jan Beneš(Institute of Clinical and Experimental Medicine), Vojtěch Melenovský(Institute for Environmental Policy)
Cited by 29
Related Papers
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction
|New England Journal of Medicine|2024|693
Baseline Characteristics of Patients with Heart Failure with Mildly Reduced or Preserved Ejection Fraction: The FINEARTS-HF Trial
|European Journal of Heart Failure|2024|62
Metformin in the management of patients with diabetes and advanced heart failure (HFrEF): a propensity score-matched analysis
|Research Square|2022|0
Metformin treatment is associated with improved outcome in patients with diabetes and advanced heart failure (HFrEF)
|Zenodo (CERN European Organization for Nuclear Research)|2022|0